Population
Unrelated patients susceptible to malignant hyperthermia (MHS)
Design
Other
Authors
Loading...
May aid MHS diagnosis in Caucasians; leaves open functional validation and broader clinical utility testing.
The discovery of the Gly341Arg mutation in the RYR1 gene, accounting for ~10% of Caucasian MHS cases, has important implications for the diagnosis and understanding of heterogeneity in malignant hyperthermia.
Quane et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: